Similar Papers

Paper Title
Journal
Date
Author
Polatuzumab Vedotin Combined with Bendamustine (B) and Rituximab (R) or Obinutuzumab (G) in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of a Phase Ib/II Dose-Escalation Study
Alex F Herrera ... Laurie H Sehn
Blood | VOL. 128
Alex F Herrera, et. al.Alex F Herrera ... Laurie H Sehn
02 Dec 2016
Quality of Life (QoL) in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (NHL) Treated with Polatuzumab Vedotin Plus Rituximab in the ROMULUS Study
Per-Olof Thuresson ... Franck Morschhauser
Blood | VOL. 134
Per-Olof Thuresson, et. al.Per-Olof Thuresson ... Franck Morschhauser
13 Nov 2019
Polatuzumab Vedotin Plus Venetoclax with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Primary Efficacy Analysis of a Phase Ib/II Study
Giuseppe Gritti ... Christopher Flowers
Blood | VOL. 136
Giuseppe Gritti, et. al.Giuseppe Gritti ... Christopher Flowers
05 Nov 2020
The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Hervé Tilly ...
Blood | VOL. 138
Hervé Tilly, et. al.Hervé Tilly ...
04 Dec 2021
View more papers

More From: American Journal of Hematology

Paper Title
Journal
Date
Author
-
-
American Journal of Hematology | VOL. 100
--
01 Feb 2025
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World.
Bruno Fattizzo ... Wilma Barcellini
American journal of hematology | VOL. -
Bruno Fattizzo, et. al.Bruno Fattizzo ... Wilma Barcellini
29 Jan 2025
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.
Michael Hallek
American journal of hematology | VOL. -
Michael HallekMichael Hallek
28 Jan 2025
Prospective Pharmacokinetic Evaluation of Venetoclax in AML Supports Re-Evaluation of Recommended Dose Adjustments With Azole Antifungals.
Jitesh D Kawedia ... Tapan M Kadia
American journal of hematology | VOL. -
Jitesh D Kawedia, et. al.Jitesh D Kawedia ... Tapan M Kadia
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.